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Disease tolerance is a defense strategy that limits
the fitness costs of infection irrespectively of path-
ogen burden. While restricting iron (Fe) availability
to pathogens is perceived as a host defense strategy,
the resulting tissue Fe overload can be cytotoxic
and promote tissue damage to exacerbate disease
severity. Examining this interplay during malaria, the
disease caused by Plasmodium infection, we find
that expression of the Fe sequestering protein ferritin
H chain (FtH) in mice, and ferritin in humans, is asso-
ciated with reduced tissue damage irrespectively
of pathogen burden. FtH protection relies on its
ferroxidase activity, which prevents labile Fe from
sustaining proapoptotic c-Jun N-terminal kinase
(JNK) activation. FtH expression is inhibited by JNK
activation, promoting tissue Fe overload, tissue
damage, and malaria severity. Mimicking FtH’s anti-
oxidant effect or inhibiting JNK activation pharmaco-
logically confers therapeutic tolerance to malaria in
mice. Thus, FtH provides metabolic adaptation to
tissue Fe overload, conferring tolerance to malaria.
INTRODUCTION
There are two evolutionarily conserved defense strategies
against infection that limit host disease severity. One relies on
the capacity of the host’s innate and adaptive immune system
to reduce pathogen burden, i.e., resistance to infection. The
salutary effects of this defense strategy are illustrated by the
protective effect of vaccination against a wide range of infectious
diseases. There is, however, another host defense strategy that
limits disease severity irrespectively of pathogen burden, i.e.,
disease tolerance (Ayres and Schneider, 2012; Medzhitov
et al., 2012; Schneider and Ayres, 2008). Revealed originally in
plants and thereafter in flies, disease tolerance also operates in
mammals, as demonstrated for Plasmodium (Ra˚berg et al.,Cell Host &2007; Seixas et al., 2009) and polymicrobial (Larsen et al.,
2010) infection in mice.
Once infected, mammals restrict Fe availability to pathogens,
reducing Fe acquisition via gut epithelial cells while inhibiting
cellular Fe export and sequestering intracellular Fe within
different tissues (Ganz, 2009; Weiss, 2002). A major ‘‘trade-off’’
of this host defense strategy is tissue Fe overload, which can
act in a pro-oxidant and cytotoxic manner to promote tissue
damage and exacerbate disease severity. Presumably, this
pathologic outcome is countered by a series of mechanisms
providing host metabolic adaptation to tissue Fe overload. We
hypothesized that these mechanisms involve the expression of
ferritin H chain (Fth), a stress-responsive gene (Torti et al.,
1988) that regulates Fe metabolism (Harrison and Arosio, 1996;
Hentze and Ku¨hn, 1996; Vanoaica et al., 2010).
FtH is an evolutionarily conserved Fe sequestering protein that
acts in a cytoprotectivemanner (Balla et al., 1992; Berberat et al.,
2003; Cozzi et al., 2003; Pham et al., 2004). This cytoprotective
effect relies on the ferroxidase activity of FtH, which converts
Fe(II) into Fe(III), hence limiting the participation of Fe(II) in the
production of free radicals via the Fenton chemistry (Pham
et al., 2004). The antioxidant effect of FtH inhibits c-Jun
N-terminal kinase (JNK) activation in vitro through a mechanism
targeting redox-sensitive phosphates and conferring cytopro-
tection (Chang et al., 2006; Kamata et al., 2005; Pham et al.,
2004). We now demonstrate that inhibition of JNK activation
by FtH confers tolerance to malaria, the disease caused by
Plasmodium infection.RESULTS
FtH Confers Tolerance to Malaria in Mice
Plasmodium chabaudi chabaudi (Pcc) infection, i.e., administra-
tion of Pcc-infected red blood cells (RBCs), was associated with
the induction of FtH expression in the liver of C57BL/6 mice (Fig-
ure 1A), namely in hepatocytes (Figures 1A and S1A). FtH protein
expression (Figure S1B) was associated with concomitant, albeit
less pronounced, Fth mRNA expression (Figure S1C). Ferritin L
chain (FtL) protein (Figure S1B) and mRNA (data not shown)
expression were not induced in the liver of Pcc-infectedMicrobe 12, 693–704, November 15, 2012 ª2012 Elsevier Inc. 693
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Figure 1. FtH Loss of Function Impairs
Tolerance to Plasmodium Infection
(A) Expression of FtH detected by immunohistol-
ogy in the liver of naive (not infected) or 7 days after
Pcc infection in Fthlox/lox mice.
(B) Survival and mean parasitemia ± SD of
Pcc-infected male Fthlox/lox (n = 6) and FthD/D (n =
18) mice.
(C) Mean percentage (parasitemia) and number of
infected RBC (iRBC) ± SD (n = 5 per group) in
Fthlox/lox versus FthD/D mice, 7 days post Pcc
infection.
(D) PCD detected by TUNEL staining (brown) in the
liver of mice, as in (C). PV: portal vein.
(E) Mean plasma AST concentration ± SD (n = 5/
group) in mice, as in (C).
(F) Mean cellular labile Fe content per mg of dry
tissue ± SD (n = 5 per group), in the liver of mice,
as in (C).
(G and H) Survival (G) and mean parasitemia ± SD
(H) of Pcc-infected FthD/D mice receiving vehicle
(PBS) (n = 5) or the Fe chelator Exjade (n = 5).
(I) HO-1 and a-tubulin (a-Tub.) expression in the
liver of individual Fthlox/lox versus FthD/D mice, de-
tected by western blot before () or 7 days after (+)
Pcc infection. Blot is representative of eight inde-
pendent experiments, with similar trends quanti-
fied by densitometry, represented as mean arbi-
trary units (A.U.) of HO-1/a-tubulin ratio ± SD.
cHO-1 indicates truncated, presumably nuclear
HO-1 (Lin et al., 2007).
(J) FtH and FtL expression in the liver of individual
C57BL/6 Hmox-1+/+ and Hmox-1/ mice, de-
tected by western blot before () or 7 days after (+)
Pcc infection. Blot is representative of four inde-
pendent experiments, with similar trends quanti-
fied by densitometry and represented as mean
arbitrary units (A.U.) of FtH/FtL ratio ± SD. See also
Figure S1.
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Ferritin H Chain Confers Disease ToleranceC57BL/6 mice. Moreover, there was no induction of FtH or FtL
protein (Figure S1D) or mRNA (Figure S1E, data not shown)
expression in heart, lung, kidney, or spleen of Pcc-infected
C57BL/6 mice.
C57BL/6 Fthlox/lox mice, carrying a Fth allele flanked by LoxP
sites and expressing physiologic levels of FtH (Figures S1F and
S1G) (Darshan et al., 2009), cleared Pcc infection without overt
lethality (Figure 1B). In contrast, C57BL/6 FthD/D mice, in which
the Fthlox/lox allele was deleted by the expression of Cre recom-
binase under the control of the Mx1 promoter (Darshan et al.,
2009; Ku¨hn et al., 1995), did not express FtH in the liver (Fig-
ure S1F) and peripheral blood (Figure S1G), succumbing to
Pcc infection (Figure 1B). Mortality of Pcc-infected FthD/D mice
was not associated with increased pathogen burden as
compared to Pcc-infected Fthlox/lox mice (Figures 1B and 1C).
Pcc-infected FthD/D mice presented liver damage, revealed by694 Cell Host & Microbe 12, 693–704, November 15, 2012 ª2012 Elsevier Inc.widespread hepatocyte programmed
cell death (PCD) (Figure 1D) and accumu-
lation of aspartate aminotransferase
(AST) in plasma (Figure 1E). This was
associated with liver Fe overload (Fig-
ure 1F). Fe chelation by Deferasirox(Exjade) protected FthD/D from infection (Figure 1G) without inter-
fering with parasitemia (Figure 1H). This shows that FtH prevents
the deleterious effects of tissue iron overload and confers
tolerance to malaria in mice.
Expression of HO-1, a stress-responsive gene that confers
tolerance to malaria in mice (Ferreira et al., 2008, 2011; Pam-
plona et al., 2007; Seixas et al., 2009), was similar inPcc-infected
Fthlox/lox versus FthD/D mice, as assessed in the liver (Figure 1I).
Expression of FtH, however, was not induced in the liver of
Pcc-infected C57BL/6 Hmox1-deficient (Hmox1/) mice (Fig-
ure 1J) that succumb to Pcc infection (Figure S1H) versus
Hmox1+/+ C57BL/6 mice that do not succumb to infection (Fig-
ure S1H). This suggests that HO-1 is required for FtH expression
in response to Pcc infection and that the protective effect of
HO-1 against Pcc infection (Seixas et al., 2009) acts via a mech-
anism involving FtH.
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Figure 2. FtH Gain of Function Confers
Tolerance to Plasmodium Infection
(A) FtH and FtL expression detected by western
blot in the liver of individual DBA/2 versus
C57BL/6 mice, not infected (Ctrl) or at the days
indicated after Pcc infection. Blots are represen-
tative of five independent experiments with similar
trend.
(B) Mean cellular labile Fe content per mg of dry
tissue ± SD in the liver of C57BL/6 versus DBA/2
mice (n = 5 per group), noninfected (), or Pcc
infected (+).
(C) FtH and a-tubulin (a-Tub.) protein expression
detected by western blot in the liver of individual
DBA/2 mice 2 days after transduction or not (Ctrl)
with LacZ, FtH, or mFtH Rec.Ad. Blots are repre-
sentative of two independent experiments, with
similar trends.
(D) Survival and mean parasitemia ± SD of Pcc-
infected DBA/2 mice nontransduced (NT) (n = 12)
or transduced with FtH (n = 20), mFtH (n = 12), or
LacZ (n = 14) Rec.Ad.
(E) Mean cellular labile Fe content per mg of dry
tissue ± SD in the liver of Pcc-infected DBA/2
mice, transduced with LacZ, FtH, or mFtH Rec.Ad.
(n = 5 per group).
(F) Mean plasma AST concentration ± SD in mice,
as in (E) (n = 5/group).
(G) PCD detected by TUNEL staining (brown)
in liver of mice. Data in (E), (F), and (G) were
pooled from three independent experiments,
with similar results. Dotted red lines in (G)
indicate areas of PCD. Images in (G) are 2003
magnification, bar = 20 mm. Data in (B), (E), (F),
and (G) are 7 days after Pcc infection. See also
Figure S2.
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Ferritin H Chain Confers Disease TolerancePcc infection is lethal in DBA/2 mice (Seixas et al., 2009),
an outcome associated with delayed FtH mRNA (Figure S2A)
and protein (Figure 2A) expression as well as with liver Fe
overload (Figure 2B), as compared to C57BL/6 mice. There
was no induction of FtL mRNA (Figure S2B) or protein (Fig-
ure 2A) expression in response to Pcc infection. Transduction
of DBA/2 mice with a recombinant adenovirus (Rec.Ad.)
encoding FtH (Figure 2C) was protective against Pcc infection
(Figure 2D), irrespectively of pathogen load (Figure 2D and
Figures S2C and S2D). Transduction with a Rec.Ad. encoding
a mutated form of FtH (mFtH) lacking ferroxidase activity
(Broxmeyer et al., 1991; Lawson et al., 1989) failed to confer
protection (Figures 2C and 2D). Transduction of DBA/2
mice with FtH but not mFtH Rec.Ad. prevented liver Fe overload
(Figure 2E) as well as liver damage, revealed by decreased
plasma AST concentration (Figure 2F) and hepatocyte
PCD (Figure 2G). Transduction with FtH versus mFtH or LacZCell Host & Microbe 12, 693–704, NRec.Ad. was also protective against liver
damage in P. berghei ANKA-infected
DBA/2 (Figure S2E) or C57BL/6 (Fig-
ure S2F) mice (Adachi et al., 2001).
This protective effect was not associ-
ated with modulation of parasitemia
(Figures S2G and S2H), showing thatthe ferroxidase activity of FtH confers disease tolerance to
malaria.
The Cytoprotective Effect of FtH Confers Tolerance
to Malaria
Plasmodium infection is associated with accumulation of heme
in plasma, as demonstrated in mice (Ferreira et al., 2011;
Pamplona et al., 2007) as well as in humans (Andrade et al.,
2010a). When released from hemoproteins, heme sensitizes
hepatocytes to undergo PCD, causing liver damage and com-
promising host survival irrespectively of pathogen burden (Goz-
zelino et al., 2010; Larsen et al., 2010; Seixas et al., 2009). When
transduced in vitro with FtH versus mFtH or LacZ Rec.Ad.,
primary mouse hepatocytes were protected against PCD
induced by heme plus TNF (Figure 3A). This was associated
with suppression of caspase-3 cleavage/activation in vitro (Fig-
ure 3B) as well as in vivo (Figure 3C), as assessed in the liver ofovember 15, 2012 ª2012 Elsevier Inc. 695
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Figure 3. The Cytoprotective Effect of FtH
against Free Heme Confers Tolerance to
Plasmodium Infection
(A) Mean cytotoxicity ± SD in mouse primary
hepatocytes transduced or not (NT) with FtH,
mFtH, or LacZ Rec.Ad. and when indicated
(+) exposed to heme (5 mM; 1 hr) plus TNF
(5 ng/ml; 16 hr).
(B) Caspase-3 (C3), cleaved caspase-3 (Cl.C3),
and a-tubulin (a-Tub.) detected by western blot
in whole-cell extracts from Hepa 1-6 cells
transduced as in (A) and when indicated (+)
exposed to vehicle or heme (40 mM; 1 hr) plus TNF
(50 ng/ml; 4 hr).
(C) Caspase-3 (C3), cleaved caspase-3 (Cl.C3),
and a-tubulin (a-Tub.) detected by western blot
in the liver of DBA/2 mice transduced or not
(NT) with FtH, mFtH, or LacZ Rec.Ad., 7 days after
Pcc infection.
(D) Mean cytotoxicity ± SD of primary hepatocytes
treated as in (A) plus caspase-3 (DEVD) or pan-
caspase (zVAD) inhibitor.
(E) Mean fold induction of NF-kB luciferase/
b-galactosidase (b-gal) activity ± SD (n = 3) in
primary hepatocytes from DBA/2 mice transduced
with Rec.Ad. encoding NF-kB-luciferase and
CMV-b-galactosidase reporters. When indicated,
hepatocytes were cotransduced with FtH or mFtH
Rec.Ad. and exposed to vehicle (), heme (+), and/
or TNF (+). Basal NF-kB luciferase/b-galactosi-
dase activity (n = 1) was taken from untreated
hepatocytes () not transduced with FtH or mFtH
Rec.Ad ().
(F) Mean fold induction of NF-kB luciferase/
b-galactosidase activity ± SD in the liver of Pcc-
infected DBA/2 mice (day 5; n = 5/group) trans-
duced with Rec.Ad. encoding NF-kB-luciferase
and CMV-b-galactosidase reporters. When indi-
cated, mice were cotransduced with FtH or mFtH
Rec.Ad. Basal NF-kB luciferase/b-galactosidase
(b-gal) activity (n = 1) was taken from mice not in-
fected () and not transduced with FtH or mFtH
Rec.Ad (). For each Rec.Ad. transduction,
noninfected (NI) mice were considered at the basal
level (n = 1). See also Figure S3.
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Ferritin H Chain Confers Disease ToleranceDBA/2 mice transduced with FtH versus mFtH or LacZ Rec.Ad..
Pharmacologic caspase-3 (z-DEVD-fmk) or broad-caspase
(z-VAD-fmk) inhibition protected primary hepatocytes from
PCD in vitro (Figure 3D), showing that heme and TNF induce
PCD via a mechanism involving caspase activation.
We asked whether the cytotoxic effect of heme acts via
a mechanism involving nuclear factor kappa B (NF-kB), a tran-
scription factor that regulates PCD (Beg and Baltimore, 1996).
Heme did not modulate NF-kB activation in response to TNF,
as assessed in vitro using a NF-kB-luciferase reporter assay in
primary mouse hepatocytes (Figure 3E). Transduction with FtH
versus mFtH or LacZ Rec.Ad. did not modulate NF-kB activation
in response to heme and/or TNF (Figure 3E). The same was true
for primary FthD/D versus Fthlox/lox hepatocytes (Figure S3A). This
shows that neither heme nor FtH modulate NF-kB activation in
response to TNF in vitro.
Pcc infection was associated with NF-kB activation, as
assessed in the liver of DBA/2 mice using an NF-kB-luciferase
reporter assay (Figure 3F). NF-kB activity was induced to696 Cell Host & Microbe 12, 693–704, November 15, 2012 ª2012 Elsa similar extent in the liver of Pcc-infected DBA/2 versus
C57BL/6 mice (Figure S3B). Transduction of DBA/2 mice with
FtH Rec.Ad. failed to modulate NF-kB activation in response to
Pcc infection, as compared to controls transduced with mFtH
or LacZ Rec.Ad. (Figure 3F). This suggests that FtH does not
modulate NF-kB activation during Pcc infection.
While transduction with a Rec.Ad. encoding the NF-kB inhib-
itor alpha (IkBa) (Figure S3C) sensitized hepatocytes to undergo
PCD in response to TNF (Figure S3D) (Soares et al., 1998; Wang
et al., 1996), as assessed at 24 hr (Figure S3D), it did not modu-
late the cytotoxic effect of heme and TNF, as assessed at 6 hr
after heme and TNF exposure (Figure S3E). This suggests that
heme and TNF induce PCD irrespectively of canonical NF-kB
activation.
The Cytoprotective Effect of FtH Relies on Its
Antioxidant Activity
The protective effect of FtH against Pcc infection was not asso-
ciated with modulation of Tnf mRNA expression, as assessedevier Inc.
Heme
TNF
- --
25
20
0
 5
LacZ Rec.Ad.
FtH Rec.Ad.
mFtH Rec.Ad.
15
10
- --
- -- - --
Pa
ra
si
te
m
ia
 (%
)
84 12 160
100
80
60
40
20
  0
Days
S
ur
vi
va
l (
%
)
Ctr
NACA
NAC
84 100 62
50
40
30
20
10
0
Days
LacZ
LacZ (H+TNF)
mFtH (H+TNF)
FtH (H+TNF)
10 100 1000 10000
ROS (CM-H2DCFDA)
1
100
 80
60
40
20
0
M
ax
im
um
 (%
)
A B
Pcc - ++ +
12
10
14
 8
4
 2
6
P
<0
.0
01
0
E
-
-
+
+
-
-
+- +
- -- +
++
C3
Cl.C3
α-Tub.
TNF
Heme
NAC
TB
A
R
S
 (F
ol
d 
In
du
ct
io
n)
C
D
+ + ++ + +
+ + ++ + +
NS
LacZ Rec.Ad.
FtH Rec.Ad.
mFtH Rec.Ad.
P<0.001
P<0.01
30
TB
A
R
S
 (n
m
ol
/m
g 
pr
ot
ei
n)
100
80
60
40
20
  0
S
ur
vi
va
l (
%
)
84 12 160
Days
Ctr
NAC
Pa
ra
si
te
m
ia
 (%
)
84 100 62
50
40
30
20
10
0
Days
60
12
F
P
<0
.0
5
P
<0
.0
00
1
Figure 4. FtH Acts as an Antioxidant
(A) Intracellular free radicals were detected by flow cytometry using the broad-spectrum free radical probe CM-H2DCFDA in Hepa 1-6 cells transduced with LacZ,
FtH, or mFtH Rec.Ad. Cells were exposed to vehicle or heme (40 mM; 1 hr) plus TNF (50 ng/ml; 2 hr). Results are representative of two independent experiments.
(B) Mean induction of cellular concentration of thiobarbituric acid reactive substances (TBARS) ± SD (n = 5) in Hepa 1-6 cells transduced with LacZ, FtH, or mFtH
Rec.Ad. Cells were exposed to heme (40 mM; 1 hr) and/or TNF (50 ng/ml; 4 hr). Basal TBARS levels were measured in Hepa 1-6 cells not exposed to heme () or
TNF (). Data from one out of two independent experiments are shown.
(C) Mean concentration of TBARS ± SD (n = 6) in the liver of DBA/2mice transduced with LacZ, FtH, or mFtH Rec.Ad. and either not infected () or 7 days after Pcc
infection. Data are pooled from three independent experiments with similar trend.
(D) Caspase-3 (C3), cleaved caspase-3 (Cl.C3), and a-tubulin (a-Tub.) detected by western blot in Hepa 1-6 cells exposed to heme and/or TNF as in (B) with or
without N-acetylcysteine (NAC; 10 mM; 4 hr before heme and maintained thereafter). Blots are representative of two independent experiments.
(E) Survival and mean parasitemia ± SD of Pcc-infected FthD/D mice receiving vehicle (PBS; n = 5) or NAC (n = 5).
(F) Survival andmean parasitemia ± SDofPcc-infected DBA/2mice receiving vehicle (PBS; n = 5), NAC (n = 5), or NACA (n = 5). NAC andNACAwere administered
at 15 mg/kg every 12 hr, i.p., from days 4 to 15 postinfection. See also Figure S4.
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Ferritin H Chain Confers Disease Toleranceby qRT-PCR in the liver of FthD/D versus Fthlox/lox mice (Fig-
ure S4A) or in the liver of DBA/2 mice transduced 2 days
before Pcc infection, with FtH versus mFtH or LacZ Rec.Ad.
(Figure S4B). Concentration of TNF (Figure S4C), total heme
(Figure S4D), or heme not bound to hemoglobin (Figure S4E)
was also similar in the plasma of Pcc-infected DBA/2 mice
transduced with FtH versus mFtH or LacZ Rec.Ad. This suggests
that it is the cytoprotective effect FtH that confers tolerance
to malaria.
Transduction of hepatocytes in vitro with an FtH Rec.Ad.
reduced the accumulation of free radicals (Figure 4A) and lipid
peroxidation (Figure 4B) in response to heme plus TNF, as
compared to control hepatocytes transduced with mFtH or
LacZ Rec.Ad. This was also observed in vivo, in the liver of
Pcc-infected DBA/2 mice transduced with FtH versus mFtH or
LacZ Rec.Ad. (Figure 4C). The glutathione precursor N-acetyl-
cysteine (NAC) suppressed caspase-3 activation in hepatocytes
exposed in vitro to heme plus TNF (Figure 4D), in keeping with its
cytoprotective effect (Seixas et al., 2009).Whenused at a dosage
(15 mg/kg) 103 lower than previously described (Seixas et al.,Cell Host &2009), NAC protected FthD/D mice from Pcc infection without
interfering with parasitemia (Figure 4E). Moreover, NAC as well
as N-acetylcysteine amide (NACA) protected DBA/2 mice from
Pcc infection without interfering with parasitemia (Figure 4F).
These observations link the protective effect of FtH with its anti-
oxidant activity.
Ferritin Expression Is Associated with Reduced Liver
Damage in Human Malaria
Similar to mice (Figures 1B, 1D, 1E, S2E, and S2F), individuals
developing symptomatic forms of malaria in response to
Plasmodium vivax infection presented varying levels of hepatic
dysfunction/damage, as quantified according to AST, C reactive
protein (CRP), and total bilirubin concentration in plasma
(Figure 5; Table S1) (Andrade et al., 2010c) (see Supplemental
Information). We have previously shown that these individuals
have higher concentrations of non-hemoglobin-bound (free)
heme and TNF in the plasma, as compared to noninfected
individuals (Andrade et al., 2010a; Mendonc¸a et al., 2012).
Higher concentrations of free heme (Figure 5A) and TNFMicrobe 12, 693–704, November 15, 2012 ª2012 Elsevier Inc. 697
Figure 5. Tolerance to Human Malaria
(A–C) Concentration of non-hemoglobin-bound
heme (free) (A), heme TNF (B), and ferritin (C) in
plasma, plotted against hepatic damage score in
individuals (N = 161) developing symptomatic
forms of malaria in response to Plasmodium vivax
infection.
(D–F) Number of parasites in the blood plotted
against hepatic damage score in the same indi-
viduals as (A), (B), and (C). Ferritin concentration
plotted against IL-6 (E) andCRP (F) concentrations
in the same individuals as (A), (B), (C), and (D).
Red lines in (E) and (F) represent curve fit for
nonparametric linear regression. Circles represent
individual values and red bars median values. See
also Figure S5 and Table S1.
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forms of malaria were associated with increased hepatic
dysfunction/damage.
Ferritin concentration in plasma was higher in individuals
infected with Plasmodium vivax versus noninfected individuals
(median and interquartile range: malaria patients 64.77,
23.58–135 ng/ml, n = 161; noninfected donors 26.5, 16.5–
40 ng/ml, n = 30, respectively; p < 0.001). However, among
individuals developing symptomatic forms of malaria, higher
ferritin concentrations in plasma were associated with reduced
severity of liver dysfunction/damage (Figure 5C). There was no
correlation between severity of liver dysfunction/damage
and pathogen load, as determined by number of parasites in
blood (Figure 5D). Higher concentrations of IL-6 and CRP in
plasma were associated with lower ferritin concentrations
(Figures 5E and 5F). This suggests that ferritin confers toler-
ance to malaria in humans and that unfettered inflammation,698 Cell Host & Microbe 12, 693–704, November 15, 2012 ª2012 Elsevier Inc.i.e., high IL-6 and CRP, is associated
with decreased ferritin expression.
Transferrin saturation (TSAT; i.e., ratio
of serum iron and total iron-binding
capacity) was increased in individuals in-
fected with Plasmodium vivax, as com-
pared to noninfected individuals (median
and interquartile range: malaria patients
33, 23%–50%, n = 161; noninfected
donors 20.0, 18.0%–35.75%, n = 30,
respectively; p < 0.001). In contrast to
ferritin, higher TSAT in individuals devel-
oping symptomatic forms of malaria
was associated with increased severity
of liver dysfunction/damage (Figure S5A),
irrespectively of pathogen burden (Fig-
ure S5B), which is consistent with pre-
vious studies (Das et al., 1997). Higher
concentrations of IL-6 (Figure S5C),
CRP (Figure S5D), and heme (Figure S5E)
in plasmawere associatedwith increased
TSAT. Moreover, there was an inverse
correlation between TSAT and ferritin
concentration in plasma (Figure S5F),
suggesting that unfettered inflammationdissociates ferritin expression from the iron status of individuals
developing symptomatic forms of malaria.
FtH Inhibits JNKActivation duringPlasmodium Infection
JNK was activated in a sustained manner in hepatocytes
exposed in vitro to heme plus TNF (Figure 6A). A similar effect
was observed in vivo, in the liver of Pcc-infected DBA/2 mice
(Figure S6A). Inhibition of JNK1/2 expression using an shRNA
Rec.Ad. protected primary mouse hepatocytes from under-
going PCD in vitro (Figure 6B), suppressing caspase-3 activation
(Figure S6B). A similar effect was obtained when JNK1/2
activation was inhibited pharmacologically (data not shown).
Transduction of hepatocytes in vitro with an FtH Rec.Ad. sup-
pressed JNK1/2 activation in response to heme plus TNF, as
compared to controls transduced with mFtH or LacZ Rec.Ad.
(Figure 6C). A similar effect was observed in vivo, in the liver of
Pcc-infected DBA/2 mice transduced with FtH versus mFtH or
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Figure 6. FtH Inhibits JNK Activation
(A) Phosphorylated (pJNK1/2) and total JNK1/2
detected by western blot in whole-cell extracts
from Hepa 1-6 cells untreated () or exposed
to heme (+) and/or TNF (+) for the indicated
time (hr).
(B) Mean cytotoxicity ± SD in Hepa 1-6 cells
transduced with Rec.Ad. and exposed to heme (+)
or heme plus TNF (+) (n = 6). Data are from one
out of two independent experiments, with similar
trend.
(C) pJNK1/2, total JNK1/2, and FtH detected as in
(A) in Hepa 1-6 cells transduced (+) or not () with
FtH, mFtH, or LacZ Rec.Ad., treated as in (A).
(D and E) Same proteins detected as in (C) in liver
extracts from (D) DBA/2mice transduced (+) or not
() with Rec.Ad. or (E) FtHlox/lox and FtHD/D mice
not infected versus 7 days after Pcc infection.
(F) Proteins detected in Hepa 1-6 cells treated as in
(A) with (+) or without () the antioxidant NAC.
(G) Proteins detected as in (A) in liver extracts
from DBA/2 mice not infected () or 7 days after
Pcc infection (+), treated (+) or not () with NAC.
Blots are representative of at least two indepen-
dent experiments, with similar trend. See also
Figure S6.
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Ferritin H Chain Confers Disease ToleranceLacZ Rec.Ad. (Figure 6D). Deletion of the Fth allele was also
associated with increased JNK1/2 activation in the liver of
Pcc-infected FthD/D versus Fthlox/lox mice (Figure 6E). NAC in-
hibited JNK1/2 activation in hepatocytes in vitro (Figure 6F)
as well as in vivo in the liver of Pcc-infected DBA/2 mice (Fig-
ure 6G). This suggests that the antioxidant effect of FtH inhibits
JNK1/2 activation in vitro as well as in vivo during Plasmodium
infection.
JNK and FtH Crossregulate Each Other to Control
Tolerance to Malaria
In keeping with previous findings suggesting that JNK contrib-
utes to the pathogenesis of severe malaria in mice (Lu et al.,
2006), we asked whether sustained JNK activation promotes
liver damage associated with Plasmodium infection. JNK1/2
expression and activity were inhibited in the liver of DBA/2
mice by transduction, 3 days before Pcc infection, of shRNA
Rec.Ad. targeting JNK1/2 (shJNK) versus a control scrambled
(shScr) Rec.Ad. (Figures S6C and S6D). JNK inhibition was
protective against Pcc infection, revealed by reduced lethality
(Figure 7A). This was associated with inhibition of liver damage,
revealed by reduced AST concentration in plasma (Figure 7B)
as well as caspase-3 activation (Figure 7C) and PCD (Figure S6E)
in the liver. This was not associated with modulation of pathogen
burden (Figures 7A, S7A, and S7B) or modulation of TNF (Fig-
ure S7C) and heme (Figures S7D and S7E) concentration in
plasma. This suggests that FtH confers tolerance to malaria via
a mechanism involving JNK inhibition.Cell Host & Microbe 12, 693–704, NPharmacologic inhibition of JNK acti-
vation using two distinct molecules, i.e.,
JNKi.SP (Figure 7D) or JNKi (data not
shown), protected DBA/2 mice from Pcc
infection without interfering with parasite-mia (Figure 7D). This shows that JNK inhibition can act therapeu-
tically to confer tolerance to malaria.
Transduction of hepatocytes in vitro with an shRNA Rec.Ad.
targeting JNK1/2 was associated with induction of FtH and FtL
protein (Figure S7F) as well as Fth mRNA (data not shown)
expression in response to heme and TNF, as compared to
control hepatocytes transduced with shScr Rec.Ad. A similar
effect was observed for FtL protein (Figure S7F), but not for
Ftl mRNA (data not shown) expression. This is consistent with
the notion that JNK can inhibit ferritin expression in vitro (Anto-
siewicz et al., 2007).
Inhibition of JNK expression in vivo was associated with
increased FtH and FtL protein (Figure 7E) as well as Fth and Ftl
mRNA (data not shown) expression, as assessed in the liver of
Pcc-infected DBA/2 mice, transduced 3 days before infection
with shJNK versus shScr Rec.Ad. (Figure 7E, data not shown).
Induction of FtH expression in DBA/2 mice transduced with
shJNK versus shScr Rec.Ad. was associated with a reduction
of liver Fe overload (Figure S7G). This suggests that JNK controls
liver Fe overload during Pcc infection via a mechanism targeting
the expression of FtH.
Pharmacologic JNK inhibition suppressed the accumulation
of free radicals in hepatocytes exposed to heme plus TNF
in vitro (Figure S7H), suggesting that JNK activation acts in
pro-oxidant manner via downregulation of FtH expression (Fig-
ure S7F). Pharmacologic JNK inhibition failed to protect FthD/D
mice from Pcc infection (Figure 7F) or to protect primary FthD/D
hepatocytes from undergoing PCD in response to heme andovember 15, 2012 ª2012 Elsevier Inc. 699
Figure 7. Functional Crosstalk between FtH
and JNK Regulates Tolerance to Malaria
(A) Survival and mean parasitemia ± SD of
Pcc-infected DBA/2 mice, not transduced (NT)
(n = 15) or transduced with shJNK (n = 18) or
control scrambled shRNA (shScr; n = 10) Rec.Ad.
(B) Mean plasma AST concentration ± SD in mice
(n = 5/group) treated as in (A), 7 days after Pcc
infection.
(C) Caspase-3 (C3), cleaved caspase-3 (Cl.C3),
JNK1/2, and a-tubulin (a-Tub.), detected by
western blot in the liver of mice treated as in (A).
(D) Survival and mean parasitemia ± SD of
Pcc-infected DBA/2 mice receiving vehicle
(DMSO in PBS) (n = 10) or JNK inhibitor SP600125
(JNKi.SP) (n = 10).
(E) FtH, FtL, and a-Tub. expression detected by
western blot, 7 days after Pcc infection in the liver
of mice treated as in (A).
(F) Survival and mean parasitemia ± SD of Pcc-
infected FthD/D C57BL/6 mice (n = 10 per group)
treated as in (D). Data in (A), (B), (D), and (F) were
pooled from three, four, two, and two independent
experiments, respectively. Blots in (C) and (E) are
representative of two independent experiments,
with similar trend. See also Figure S7.
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Ferritin H Chain Confers Disease ToleranceTNF in vitro (Figure S7I). This suggests that (1) the cytotoxic
effect of JNK acts in vitro and in vivo via a mechanism
involving the downregulation FtH expression and (2) the
protective effect of JNK inhibition is dependent on the expres-
sion of FtH.
Given that NF-kB can regulate FtH expression (Kwak et al.,
1995; Pham et al., 2004), we asked whether JNK regulates FtH
expression via a mechanism involving NF-kB. Transduction of
primary mouse hepatocytes with shJNK versus shScr Rec.Ad.
did not modulate NF-kB activation in response to heme and/or
TNF, as assessed in vitro using an NF-kB luciferase assay (Fig-
ure S7J). This suggests that JNK regulates FtH expression via
a mechanism that does not involve NF-kB.
DISCUSSION
Resistance to infection, such as afforded by vaccination, confers
protection against a broad range of infectious diseases. Given its
overwhelming success, it has been difficult to understand why
vaccination has so far failed to provide robust protection against700 Cell Host & Microbe 12, 693–704, November 15, 2012 ª2012 Elsevier Inc.specific infectious diseases such as ma-
laria (Agnandji et al., 2011). This may be
explained by the recognition that protec-
tion againstmalaria relies on an additional
host defense strategy that does not target
directly the pathogen, i.e., disease toler-
ance (Medzhitov et al., 2012; Ra˚berg
et al., 2007; Seixas et al., 2009).
Life-threatening complications of ma-
laria are driven by multiorgan dysfunc-
tion/damage associated with unfettered
inflammation (Miller et al., 2002). Heme
accumulation in the plasma of individualsdeveloping symptomatic forms of malaria (Andrade et al., 2010a)
acts in a cytotoxic manner (Gozzelino et al., 2010; Seixas et al.,
2009), contributing in a critical manner to the pathogenesis of
severe forms of malaria in mice (Ferreira et al., 2008, 2011; Pam-
plona et al., 2007; Seixas et al., 2009). In keeping with this notion,
expression of stress-responsive genes that counter the delete-
rious effects of heme, e.g., the heme catabolizing enzyme HO-
1, provide tissue damage control and confer tolerance to malaria
in mice (Ferreira et al., 2011; Pamplona et al., 2007; Seixas et al.,
2009; Soares et al., 2009). The pathophysiologic relevance of
this host protective response is supported by the finding that
sickle trait, selected through human evolution based on its ability
to confer protection against malaria, acts via activation of this
stress-responsive pathway to confer disease tolerance to ma-
laria (Ferreira et al., 2011; Rosenthal, 2011). Whether the protec-
tive effect of HO-1 impacts on the outcome of human malaria is
not clear (Mendonc¸a et al., 2012; Sambo et al., 2010; Walther
et al., 2012).
As demonstrated hereby, themechanism underlying tolerance
to malaria involves another stress-responsive gene, namely
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Ferritin H Chain Confers Disease ToleranceFtH, a Fe-sequestering protein that regulates Fe metabolism
(Darshan et al., 2009; Harrison and Arosio, 1996; Hentze et al.,
1987), limiting the cytotoxic effect of labile Fe (Balla et al., 1992;
Berberat et al., 2003; Cozzi et al., 2003; Pham et al., 2004).
Expression of FtH is induced in response to Plasmodium infec-
tion in mice (Figures 1A, 2A, and S1A–S1C) as well as in humans
(Das et al., 1997). Presumably, the mechanism regulating the
induction of FtH expression during malaria acts at a posttran-
scriptional level, driven by Fe generated through heme catabo-
lism by HO-1 (Figure 1J) (Berberat et al., 2003; Eisenstein
et al., 1991). Whether induction of FtH correlates with a threshold
of parasitemia is not clear.
The salutary effect of FtH against Plasmodium infection acts
irrespectively of pathogen load, conferring disease tolerance to
malaria in mice (Figures 1 and 2) and presumably in humans (Fig-
ure 5). This suggests that individuals failing to upregulate the
expression of FtH might be at higher risk of developing severe
forms of malaria.
The cytoprotective effect of FtH relies on its ferroxidase
activity (Figures 2 and 3) (Balla et al., 1992; Berberat et al.,
2003; Cozzi et al., 2003; Pham et al., 2004), which limits the
participation of labile Fe in the Fenton chemistry, thus inhibiting
the production of free radicals (Figure 4). This in turn inhibits sus-
tained JNK activation, as demonstrated in vitro (Figure 6C) as
well as in vivo (Figures 6D and 6E). The salutary effects of FtH
are mimicked by pharmacologic antioxidants such as NAC or
NACA (Figures 4E and 4F). These inhibit JNK activation in vitro
(Figure 6F) as well as in vivo (Figure 6G), conferring tolerance
to malaria in mice (Figures 4E and 4F).
Sustained JNK activation, catalyzed by labile Fe produced
during Plasmodium infection, plays a central role in the patho-
genesis of severe malaria in mice (Figure 7). This notion is in
keeping with the previous observation that deletion of the Jnk2
allele confers protection against experimental cerebral malaria
in mice (Lu et al., 2006), without interfering with pathogen load
(Figures 7A, 7D, S7A, and S7B) (Lu et al., 2006). This suggests
that targeting JNK activation might be used therapeutically to
confer tolerance to malaria, which we found to be the case in
mice (Figure 7D).
The mechanism via which JNK activation compromises
tolerance to malaria involves the inhibition of FtH expression
(Figures 7E, 7F, and S7F), leading to tissue Fe overload
(Figure S7G), accumulation of free radicals (Figure S7H), cyto-
toxicity (Figures 6B, 7C, and S6B), tissue damage (Figures 7B
and S6E), and ultimately host mortality (Figures 7A and 7D).
We propose that induction of FtH expression during Plasmodium
infection prevents pro-oxidant labile Fe from sustaining JNK
activation, presumably via a mechanism involving the inhibition
of redox-sensitive phosphatases regulating directly JNK
activity (Chang et al., 2006; Kamata et al., 2005; Pham et al.,
2004). Induction of FtH expression requires the expression of
HO-1 (Figure 1J), thus suggesting that FtH contributes in a critical
manner to the salutary effect of HO-1 against malaria (Fig-
ure S1H) (Seixas et al., 2009; Soares et al., 2009).
In conclusion, the pathogenesis of life-threatening complica-
tions of malaria is regulated by a functional crosstalk between
FtH and JNK that controls host metabolic adaptation to tissue
Fe overload during Plasmodium infection. FtH promotes toler-
ance to malaria, via inhibition of JNK activation, while JNKCell Host &activation promotes the pathogenesis of life-threatening compli-
cations of malaria via inhibition of FtH expression. Whether FtH
promotes tolerance to other types infection is likely to be the
case, but this remains to be established.
EXPERIMENTAL PROCEDURES
Mice
Mice were bred and maintained under specific pathogen-free (SPF) condi-
tions, according to protocols approved by local (Instituto Gulbenkian de
Cieˆncia) and national (Portuguese Official Veterinary Department; Direcc¸a˜o
Geral de Veterina´ria) ethics committees. C57BL/6 Fthlox/lox mice (Darshan
et al., 2009) were obtained originally from Lukas Ku¨hn (Ecole Polytechnique
Fe´de´rale de Lausanne, Faculte´ des Sciences de la Vie, Institut Suisse de
Recherche Expe´rimentale sur le Cancer).
Conditional Gene Deletion (D)
C57BL/6 Fthlox/lox mice were crossed with transgenic C57BL/6 Mx-Cre mice
expressing the Cre recombinase under the control of the ubiquitous
poly(I:C)-inducible Mx1 promoter (Darshan et al., 2009; Ku¨hn et al., 1995).
Infections
Mice were infected intraperitoneally (i.p.) with 107 Plasmodium chabaudi
chabaudi (Pcc) AS strain or 106 Plasmodium berghei ANKA-infected RBCs,
referred to throughout the text as infection. Survival and parasitemia were
monitored daily as described (Pamplona et al., 2007; Seixas et al., 2009).
Primary Mouse Hepatocytes and Cytotoxicity Assay
Primarymouse hepatocytes were isolated essentially as described (Gonc¸alves
et al., 2007; Seixas et al., 2009), and cytotoxicity was assessed as described
(Gozzelino et al., 2010; Larsen et al., 2010; Seixas et al., 2009).
Cell Culture and Reagents
Hepa 1-6 cells (C57BL/6 mouse liver hepatoma; ATCC, Barcelona, Spain)
were cultured in DMEM (Invitrogen, Barcelona, Spain), 10% FCS, penicillin
(20 U/ml), and streptomycin (20 U/ml) (Invitrogen) (37C, 95% humidity, 5%
CO2), as described (Larsen et al., 2010; Seixas et al., 2009). Ammonium iron(II)
sulfate hexahydrate (NH4)2Fe(SO4)2$6H2O and N-acetylcysteine (NAC)
(Sigma, Sintra, Portugal), N-acetylcysteine amide (NACA) (provided by
Dr. Glenn Goldstein, David Pharmaceuticals, New York), Exjade (Deferasirox,
Novartis), mouse recombinant TNF (R&D Systems, Lisbon), heme (hemin,
Frontier Scientific, Lancashire, UK), z-VAD-fmk and z-DEVD-fmk (MP
Biomedicals, Porto, Portugal), SP600125 (LC Laboratories, Woburn, MA),
JNK Inhibitor I (Alexis, Lausanne, Switzerland), and 5- (and 6-)chloromethyl-
2070-dichlorodihy, drofluorescein diacetate acetyl ester (CM-H2DCFDA)
(Invitrogen) were used as indicated.
In Vivo Treatments
NAC and NACA were dissolved in PBS, adjusted to pH 7.4, and administered
to DBA/2 mice (15 mg/kg i.p.) starting at day 4 postinfection and every 12 hr
thereafter until day 15. The same dosage and schedule protocol was used in
FthD/D mice. JNKi.SP was dissolved in DMSO and administered to DBA/2
mice (2.5 mg/kg in DMSO 0.2% v/v, i.p., once a day) starting at day 4 postin-
fection until day 15. Exjade (Deferasirox, Novartis) was dissolved in PBS and
administered to FthD/D mice (10 mg/kg by gavage, once a day) starting at
day 3 postinfection until day 15.
Recombinant Adenovirus
Generation of FtH and mFtH Rec.Ad. were previously described (Berberat
et al., 2003). Rec.Ad. encoding a mutated form of IkBa (IkBa S32A/S36A)
(Vector Biolabs, http://www.vectorbiolabs.com), b-galactosidase (LacZ)
Rec.Ad. (a kind gift from Dr. R. Gerard, University of Texas Southwest Medical
Center, Dallas, TX), and NF-kB luciferase reporter (Photinus pyralis luciferase
gene under the control of a synthetic promoter containing five binding motifs
for NF-kB [50-GGGGACTTTCC-30; NF-kB-Luc] [Vector Biolabs]) were previ-
ously described (Silva et al., 2009). Oligonucleotides used to construct
a shRNA targeting JNK were previously described (Gururajan et al., 2005).Microbe 12, 693–704, November 15, 2012 ª2012 Elsevier Inc. 701
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Rec.Ad.) were produced by Vector Biolabs.
Histopathology
Mice were perfused in toto with ice-cold PBS. Liver samples were harvested,
fixed in 4% paraformaldehyde (PFA), embedded in paraffin, and stained with
hematoxylin and eosin as described (Pamplona et al., 2007). Detection of
fragmented DNA in liver was carried out using the TUNEL method (In Situ
Cell Death Detection Kit, Roche). FtH staining was performed as follows: Liver
samples were collected in Tissue-Tek (Sakura), snap frozen in liquid nitrogen,
and kept at80C until used. Liver samples were fixed in 1%PFA (15min) and
permeabilized with Triton X-100 (10min), blocked with 5% goat serum and 1%
BSA (60 min), and incubated with rabbit-anti-mouse FtH (1:100 dilution,
overnight at 4C) diluted in the same solution. Goat-anti-rabbit-Cy5 (1:300
dilution, 60 min) was used as a secondary antibody. DAPI reagent (15 min)
was employed as nuclear stain. Cell autofluorescence (green; excitation l =
480 nm, emission l = 505) was used to detect hepatocyte morphology.
Human Samples
Plasma was collected between 2006 and 2007 from symptomatic individuals
(N = 161) infected with Plasmodium vivax in Buritis, Rondoˆnia, Brazil, as
described before (Andrade et al., 2010a, 2010b, 2010c, 2011). Malaria diag-
nosis was performed using microscopic examination of thick smears and
confirmed by qualitative nested PCR, as described (Andrade et al., 2009).
Parasitemia was expressed as parasites/ml. Plasma samples from 30 age-
and sex-matched healthy and noninfected individuals from the same malaria
endemic area were used to compare ferritin and transferrin saturation levels
with the cohort of individuals infected with Plasmodium vivax.
Hepatic Damage Score
Aspartate transaminase (AST), total bilirubin, and c-reactive protein (CRP)
were measured in plasma samples obtained from individuals with P. vivax
malaria in order to build a scoring system allowing us to assess in a quantitative
manner hepatic damage severity (adapted from Andrade et al., 2010c). These
parameters were measured at the clinical laboratory of Faculdade Sa˜o Lucas
and at the Pharmacy School of the Federal University of Bahia, Brazil.
Statistical Analysis
Data analysis was performed using unpaired Student’s t test for data
presenting Gaussian distributions, an assumption tested using the Kolmo-
gorov-Smirnov method. When data did not follow Gaussian distribution,
Mann-Whitney U test was used instead. Log-rank test was used when survival
was assessed as an end point. Data from human samples were also tested for
Gaussian distribution, and differences between the groups presented with
diverse hepatic damage scores were analyzed using Kruskal-Wallis test with
Dunn’s multiple comparisons or nonparametric Kendal linear trend post test.
The linear trend post test was used to evaluate the pattern of variation of
free heme, TNF, ferritin, transferrin saturation, or parasite load correlating
with the ascending degree of hepatic damage. The statistical analysis of the
human data was performed using STATA10 software (StataCorp LP, College
Station, TX). Correlations between free heme, TNF, CRP, IL-6, ferritin, trans-
ferrin saturation, parasitemia, hepatic damage score, and creatinine were
analyzed by Spearman nonparametric test. Nonlinear curve fit models were
used to illustrate the overall trend of data variation. p < 0.05 was considered
significant.
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